Over the next several years, specific therapeutic areas are forecasted to grow at astonishing rates. The global vaccine market, for example, is expected to achieve $34 billion in sales by 2012, making it one of the fastest-growing therapeutic areas, even outpacing oncology. The recently renewed interest in the vaccine sector is attributed to advances in technology, federal liability protection for developers, increasing global demand, and premium pricing for new products.

January 14, 2011

2 Min Read
How Tech Advances Drive Therapy

Other therapeutic areas, such as wound care and diagnostics, are also transforming due to advances in technology. Traditional wound-care products are growing at unusually slow rates while advanced wound-care segments are forecasted to grow more than $16 billion by 2017. Driven by new scientific knowledge, technological innovations, growing interest by stakeholders, an aging society, and increasing demand in emerging regions, the global molecular diagnostics market is predicted to reach $6.35 billion by 2015.
 

Although technology advances in many therapeutics fields are helping bolster sales, improvements in other areas such as cancer and diabetes are still needed. Cancer is the second leading cause of deaths each year in the United States, however, medications on average are only 25% effective in the advanced disease setting, creating an urgent need for effective cancer diagnostics and treatments.
 

More than 230 million people worldwide have been diagnosed with diabetes and this number is expected to rise to a staggering 350 million within 20 years. Approximately 60% of diabetes patients do not achieve target blood glucose levels with their current treatments. Developers in the medical device and pharma markets are working diligently on an "artificial pancreas" that is anticipated to be on the market within the near future.
 

Therapeutic Categories Review includes the following PharmaLive special reports: Cardiovascular Review and Outlook, CNS Review and Outlook, Diabetes Review and Outlook, Diagnostics Imaging and Device Review and Outlook, Oncology Review and Outlook, Personalized Medicine and Orphan Drugs Review and Outlook, Vaccines Review and Outlook, Weight Management Review and Outlook, and Wound Care Review and Outlook.
 

More information is available in Therapeutic Categories Review, available at www.pharmalive.com/special_reports

For additional information, contact Sandra Baker at +1-215-944-9836 or [email protected].

About UBM Canon Data Products
UBM Canon Data Products provide financial, company, and product statistical data and qualitative analysis for the global pharmaceutical, biotechnology, medical device, and appliance industries through PharmaLive Special Reports and Appliance Market Research Reports; maintains eKnowledgeBase and MDRWeb, comprehensive market intelligence tools serving the pharmaceutical, biotechnology, and medical-device sectors; and manages company-wide Site Licenses for PharmaLive.com, Med Ad News, and R&D Directions.

About UBM Canon
UBM Canon is a business-to-business media company serving the worldwide advanced manufacturing sector through its publications, trade events, and electronic media.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like